Explore our comprehensive coverage of healthcare policy, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The enforcement of Medicare drug price negotiations, coupled with massive GLP-1 manufacturing expansions and aggressive FTC antitrust actions, is fund...
Read Full Story →
Healthcare PolicyThe simultaneous collision of CMS Medicare Advantage risk-adjustment cuts, FTC PBM merger blocks, an...
![[The Algorithmic Tollbooth: How October's Healthcare Directives Expose the Terminal Friction of the Modern Medical State]](https://www.crimaz.com/assets/images/no-image.png)
Healthcare Policy[October 2026's convergence of CMS risk adjustments, FDA AI reimbursement codes, and the FTC's PBM a...
Healthcare PolicyThe FTC's ban on PBM spread pricing and the CMS mandate for AI-driven prior authorizations are struc...
Healthcare PolicyThe simultaneous implementation of Medicare GLP-1 step-therapy mandates, the AMA's AI diagnostic lia...
Healthcare PolicyThe global healthcare policy sector is undergoing a severe structural reset as PBM monopsony enforce...
Healthcare PolicyThe CMS downside risk mandate, the Medicare Part D liability shift, and the FDA's AI prior-authoriza...
